MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/gerona/glad268

Медицинская библиотека · The journals of gerontology. Series A, Biological sciences and medical sciences · 2024

Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.

Zhou Zhen, Tonkin Andrew M, Curtis Andrea J, Murray Anne, Zhu Chao, Reid Christopher M, Williamson Jeff D, Ryan Joanne, McNeil John J, Beilin Lawrence J, Ernst Michael E, Stocks Nigel, Lacaze Paul, Shah Raj C, Woods Robyn L, Wolfe Rory, Gall Seana, Zoungas Sophia, Orchard Suzanne G, Nelson Mark R

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАКлиническое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The prognostic implication of cholesterol levels in older adults remains uncertain. This study aimed to examine the relationship between low-density-lipoprotein cholesterol (LDL-c) and mortality outcomes in older individuals.

METHODS

This post hoc analysis examined the associations of LDL-c levels with mortality risks from all-cause, cardiovascular disease (CVD), cancer, and combined non-CVD/noncancer conditions in a cohort of individuals aged ≥65 years from the ASPirin in Reducing Events in the Elderly trial (NCT01038583). At baseline, participants had no diagnosed dementia, physical disability, or CVD, and were not taking lipid-lowering agents. Outcome analyses were performed using multivariable Cox models.

RESULTS

We analyzed 12 334 participants (mean age: 75.2 years). Over a median 7-year follow-up, 1 250 died. Restricted cubic splines found a U-shaped relation for LDL-c and all-cause mortality, cancer mortality, and noncancer/non-CVE mortality (nadir: 3.3-3.4 mmol/L); the risk of CVD mortality was similar at LDL-c below 3.3 mmol/L and increased above 3.3 mmol/L. Similar trends were observed in analyses modeling LDL-c by quartiles. When modeling LDL-c as a continuous variable, the risk of all-cause mortality, cancer mortality, and noncancer/non-CVD mortality was decreased by 9%, 16%, and 18%, respectively, per 1-mmol/L higher LDL-c, and the risk of CVD mortality was increased by 19% per 1-mmol/L higher LDL-c. Reduced all-cause and non-CVD/noncancer mortality risks were only significant in males but not females (pinteraction < .05).

CONCLUSIONS

There were U-shaped relationships between LDL-c and all-cause mortality, cancer mortality, and noncancer/non-CVD mortality in healthy older adults. Higher LDL-c levels were associated with an increased risk of CVD mortality. Future studies are warranted to confirm our results.

Для цитирования: Zhou Zhen, Tonkin Andrew M, Curtis Andrea J, Murray Anne, Zhu Chao, Reid Christopher M, Williamson Jeff D, Ryan Joanne, McNeil John J, Beilin Lawrence J, Ernst Michael E, Stocks Nigel, Lacaze Paul, Shah Raj C, Woods Robyn L, Wolfe Rory, Gall Seana, Zoungas Sophia, Orchard Suzanne G, Nelson Mark R. Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.. The journals of gerontology. Series A, Biological sciences and medical sciences. 2024. DOI: 10.1093/gerona/glad268.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.